LncRNA FOXC2-AS1 protects cardiomyocytes from doxorubicin-induced cardiotoxicity through activation of WNT1-inducible signaling pathway protein-1

References

• Zhang M, Jiang L. Doxorubicin hydrochloride-loaded mesoporous silica nanoparticles inhibit non-small cell lung cancer metastasis by suppressing VEGF-mediated angiogenesis[J]. J Biomed Nanotechnol. 2016;12(11):1975–1986.
   PubMed Web of Science ®Google Scholar
• Sikov WM, Berry DA, Perou CM, et al. Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)[J]. J Clin Oncol. 2015;33(1):13–21.
   PubMed Web of Science ®Google Scholar
• Tahover E, Patil YP, Gabizon AA. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes[J]. Anticancer Drugs. 2015;26(3):241–258.
   PubMed Web of Science ®Google Scholar
• Ferreira ALA, Matsubara LS, Matsubara BB. Anthracycline-induced cardiotoxicity[J]. Cardiovasc Hematol Agents Med Chem. 2008;6(4):278–281.
   PubMedGoogle Scholar
• Salvatorelli E, Guarnieri S, Menna P, et al. Defective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart. Relative importance of vesicular sequestration and impaired efficiency of electron addition[J]. J Biol Chem. 2006;281(16):10990–11001.
   PubMed Web of Science ®Google Scholar
• Zhang CL, Zhu KP, Shen GQ, et al. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma[J]. Tumour Biol. 2016;37(2):2737–2748.
   PubMedGoogle Scholar
• Jiang M, Huang O, Xie Z, et al. A novel long non-coding RNA-ARA: adriamycin resistance associated[J]. Biochem Pharmacol. 2014;87(2):254–283.
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function[J]. Nat Rev Genet. 2016;17(1):47–62.
   PubMed Web of Science ®Google Scholar
• Zhang CL, Zhu KP, Ma XL. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2[J]. Cancer Lett. 2017;396:66–75.
   PubMed Web of Science ®Google Scholar
• Venkatesan B, Prabhu SD, Venkatachalam K, et al. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death[J]. Cell Signal. 2010;22(5):809–820.
   PubMed Web of Science ®Google Scholar
• Ayers M, Symmans WF, Stec J, et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer[J]. J Clin Oncol. 2004;22(12):2284–2293.
   PubMed Web of Science ®Google Scholar
• Folgueira MAAK, Carraro DM, Brentani H, et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer[J]. Clin Cancer Res. 2005;11(20):7434–7443.
   PubMed Web of Science ®Google Scholar
• Zhu KP, Zhang CL, Shen GQ, et al. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis[J]. Int J Clin Exp Pathol. 2015;8(8):8754–8773.
   PubMed Web of Science ®Google Scholar
• Yang H, Chen T, Xu S, et al. Long non-coding RNA FOXC2-AS1 predicts poor survival in breast cancer patients and promotes cell proliferation[J]. Oncol Res. 2018. DOI:10.3727/096504018X15213126075068.
   Google Scholar
• Berschneider B, Königshoff M. WNT1 inducible signaling pathway protein 1 (WISP1): a novel mediator linking development and disease[J]. Int J Biochem Cell Biol. 2011;43(3):306–309.
   PubMed Web of Science ®Google Scholar
• Li L, Guleria RS, Thakur S, et al. Thymosin β4 prevents angiotensin II‐induced cardiomyocyte growth by regulating Wnt/WISP signaling[J]. J Cell Physiol. 2016;231(8):1737–1744.
   PubMed Web of Science ®Google Scholar
• Wright LH, Herr DJ, Brown SS, et al. Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling[J]. JCI Insight. 2018;3(4):e95824.
   Web of Science ®Google Scholar
• Maeda A, Ono M, Holmbeck K, et al. WNT1-induced secreted protein-1 (WISP1), a novel regulator of bone turnover and Wnt signaling[J]. J Biol Chem. 2015;290(22):14004–14018.
   PubMed Web of Science ®Google Scholar
• Shao H, Cai L, Moller M, et al. Notch1-WISP-1 axis determines the regulatory role of mesenchymal stem cell-derived stromal fibroblasts in melanoma metastasis[J]. Oncotarget. 2016;7(48):79262–79273.
   PubMedGoogle Scholar
• Berschneider B, Ellwanger DC, Baarsma HA, et al. miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis[J]. Int J Biochem Cell Biol. 2014;53:432–441.
   PubMed Web of Science ®Google Scholar
• Carvalho FS, Burgeiro A, Garcia R, et al. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy[J]. Med Res Rev. 2014;34(1):106–135.
   PubMed Web of Science ®Google Scholar